Management Team
Board of Directors
Corporate Governance
BEMA Technology
Onsolis
BEMA Buprenorphine
Publications
BUNAVAIL™
Topical Clonidine Gel
SEC Filings
Section 16 (Insider Filings)
XBRL
Annual Report
Presentation and Events
Investor Alerts
Directions
Employment Opportunities
Investor Relations
» XBRL
XBRL
If your browser does not automatically open a new window:
Click Here
Top News
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2013 Financials
NDA filing for BUNAVAIL on track for mid-summer 2013
BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
BioDelivery Sciences Appoints Thomas W. D'Alonzo to Board of Directors
VIDEO
BDSI – 2013 Milestones